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TRIM31 promotes Atg5/Atg7-independent
autophagy in intestinal cells
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Autophagy is responsible for the bulk degradation of cytosolic constituents and plays an
essential role in the intestinal epithelium by controlling beneﬁcial host–bacterial relationships.
Atg5 and Atg7 are thought to be critical for autophagy. However, Atg5- or Atg7-deﬁcient cells
still form autophagosomes and autolysosomes, and are capable of removing proteins or
bacteria. Here, we report that human TRIM31 (tripartite motif), an intestine-speciﬁc protein
localized in mitochondria, is essential for promoting lipopolysaccharide-induced Atg5/Atg7-
independent autophagy. TRIM31 directly interacts with phosphatidylethanolamine in a
palmitoylation-dependent manner, leading to induction of autolysosome formation. Depletion
of endogenous TRIM31 signiﬁcantly increases the number of intestinal epithelial cells
containing invasive bacteria. Crohn’s disease patients display TRIM31 downregulation.
Human cytomegalovirus-infected intestinal cells show a decrease in TRIM31 expression as
well as a signiﬁcant increase in bacterial load, reversible by the introduction of wild-type
TRIM31. We provide insight into an alternative autophagy pathway that protects against
intestinal pathogenic bacterial infection.
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T
he intestinal epithelium interfaces with a dense microbial
community and is an essential site for eliminating
invasive bacteria and limiting further dissemination1.
However, several invasive intestinal pathogens, such as
Salmonella Typhimurium or Shigella ﬂexneri, can achieve
penetration of epithelial cells and threaten host intestinal
health2,3. This suggests that intestinal cell-intrinsic immune
responses are required to block invading bacteria and prevent
their spread to extra-intestinal sites.
A primary role of autophagy is to maintain cellular
homoeostasis by degrading intracytoplasmic proteins and
organelles through starvation and by recycling multiple
sources4–6. More recently, autophagy has been established as a
critical process for the recognition and elimination of intracellular
pathogens, thus acting as an important defensive barrier against
bacterial invasion7,8. A genome-wide association study revealed
several autophagy regulatory proteins with essential functions
in intestinal immune homoeostasis7. In particular, mutations in
the crucial autophagy protein Atg16L1 are tightly correlated
with increased risk of Crohn’s disease in humans8–10. However,
a mutation in Atg16L1 still exhibits autophagy in mice11.
In addition, it is well known that Atg5 and Atg7 are critical for
autophagy12,13; however, equivalent numbers of LC3-positive and
-negative autophagosomes were found in Atg5- or Atg7-deﬁcient
cells14. Furthermore, protein degradation or mycobacteria
sequestration can occur through alternative Atg5- or Atg7-
independent autophagy pathways14–16, indicating that canonical
and non-canonical autophagy occur simultaneously. Particularly,
intestinal tissue, which interfaces with a diversity of commensal
bacteria, may actively mediate both conventional and alternative
pathways to maintain intestinal immune homoeostasis.
The tripartite motif (TRIM) family of proteins, which contribute
to a broad range of biological events, consist of a RING domain,
one or two B-boxes and a coiled-coil domain17. Additionally, most
TRIMs possess a variable C-terminal region, which may play a role
in substrate binding. Although studies have shown that several
TRIMs affect autophagy18–20, the functional role of the intestine-
speciﬁc TRIM31 in autophagy has yet to be fully elucidated. Here,
we report that TRIM31 plays a critical role in the formation of
autolysosomes in Atg5 /or Atg7 / cells, thus promoting
elimination of invading bacteria through an Atg5- or Atg7-
independent alternative pathway in the intestinal cells.
Results
TRIM31 is downregulated in Crohn’s disease. A recent study
has shown that TRIM31 expression in human tissues is limited to
digestive tissues such as the colon and small intestine among
normal tissues21. Consistent with a previous report, our data
conﬁrmed this tissue-speciﬁc expression of TRIM31 in human
colonic and intestinal epithelial cells among various human
cell lines (Fig. 1a,b). Because TRIM family proteins are distributed
in a variety of cellular compartments involved in diverse
biological processes, we ﬁrst sought to determine the subcellular
localization of TRIM31 to understand its function.
We tested various subcellular markers for the endoplasmic
reticulum, Golgi apparatus, nucleus, cytoskeleton, lysosomes and
mitochondria in HeLa and intestinal epithelial cells. Most of the
surveyed organelles exhibited little or no TRIM31 expression;
however, TRIM31 was found associated with the mitochondria
and lysosomes as punctate structures (Fig. 1c; Supplementary
Fig. 1a,b). Interestingly, high-resolution imaging showed that the
TRIM31-containing structures were in close proximity with
mitochondria and dangled from mitochondrial tubules (Fig. 1c,
arrowheads). To conﬁrm these results, we performed subcellular
fractionation for mitochondria and the cytosol. TRIM31 was
found enriched in the mitochondrial fraction with a very small
percentage of the protein found in the cytoplasmic fraction
(Fig. 1d). We next examined whether mitochondria-targeted
TRIM31 is incorporated in or attached to mitochondria. To
test this, we treated mitochondria at alkaline pH, conditions
that lead to the extraction of soluble and peripheral membrane
proteins, whereas integral membrane proteins remain
incorporated22,23. TRIM31 was highly enriched in the soluble
fraction after alkalization, which is different from membrane-
integrated TOM20, suggesting that TRIM31 is attached to the
mitochondria (Fig. 1e).
To explore the functional roles of TRIM31 in intestine, we
next examined TRIM31 expression in samples from patients
with Crohn’s disease or controls. Crohn’s disease, a type of
inﬂammatory bowel disease (IBD) in which inﬂammation is
localized to the distal small intestine and variable regions in the
colon7. Interestingly, TRIM31 was distributed throughout the
ileal epithelium and predominantly enriched in the lower regions
of the crypts, which contain Paneth cells (Fig. 1f, red arrows).
Previous reports demonstrated that Crohn’s disease leads to
destruction of the intestinal crypt7,24,25, which we also observed
in the crypt regions (Fig. 1f, bottom panel). Remarkably, TRIM31
expression decreased by B45% in Crohn’s disease patients
compared with normal ileum tissues (Fig. 1f, right graph).
Additionally, in contrast to normal samples, the level of TRIM31
mRNA in Crohn’s disease patients decreased by 85%, suggesting
that TRIM31 is downregulated in Crohn’s disease due to a defect
in transcription (Fig. 1g,h). Taken together, these results suggest
that TRIM31 expression is tightly controlled in a tissue-speciﬁc
manner, and expression of TRIM31 may associate with the
epithelial function of the intestine mucosa or intestinal immune
homoeostasis.
TRIM31 induces autophagy. Recent studies suggest that
mitochondria can participate autophagosome biogenesis by
supplying the membrane source26. In addition, Paneth cells
play a role in control of intestinal microbiota by secretion of
antimicrobial peptides and by regulation of autophagy
process11,27. TRIM31 was enriched in the mitochondria and its
aberrant expression with very low intensity was shown in samples
from Crohn’s disease patients (Fig. 1f–h), leading us to focus our
investigation to TRIM31 and its role in autophagy. We therefore
examined whether the TRIM31-positive puncta overlap with
expression of the late autophagosomal marker, LC3. Under
normal conditions, LC3 is distributed between the cytoplasm and
nucleus with very little detected on autophagic vesicles. Once
induced by a starvation response, LC3 is recruited to
autophagosomal membranes28,29. Unexpectedly, endogenous
TRIM31-positive structures partially overlapped with LC3-
positive autophagosomes under normal conditions (Fig. 2a,
upper panel). We also found that starved intestinal cells
displayed dramatic accumulation of TRIM31-expressing
structures, which overlapped with LC3 staining (Fig. 2a, lower
panel). Furthermore, HeLa cells overexpressing TRIM31 showed
intense LC3-speciﬁc staining even under normal conditions
(Fig. 2b). Cells treated with chloroquine, a lysosomal inhibitor
that leads to an accumulation of autophagic vacuoles, produced
an intense, clumped and vesicular pattern of TRIM31 staining
relative to untreated cells, which exhibited relatively weak
TRIM31 staining (Supplementary Fig. 2a). Additionally,
because degradation of p62 has been used as a marker for the
induction of autophagy30–32, we measured the level of
endogenous p62 as a function of TRIM31-mediated autophagic
activity. Consistent with previous results, TRIM31-expressing
cells showed a signiﬁcant increase in p62 degradation
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11726
2 NATURE COMMUNICATIONS | 7:11726 | DOI: 10.1038/ncomms11726 | www.nature.com/naturecommunications
(Supplementary Fig. 2b). Thus, these ﬁndings indicate that
TRIM31 may be directly involved in autophagy.
To clarify the involvement of TRIM31 on autophagy, we
assessed the conversion of LC3-I to LC3-II in TRIM31-over-
expressing cells. Notably, expression of Myc-tagged TRIM31
signiﬁcantly induced an accumulation of LC3-II even in the
absence of starvation (Fig. 2c,d), suggesting that human TRIM31
induces autophagy even under nutrient-replete conditions.
Because the conserved Atg5–Atg12–Atg16 complex binds
directly to the pre-autophagic membranes, we examined whether
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Figure 1 | Human TRIM31 is enriched in the mitochondria and downregulated in Crohn’s disease. (a,b) TRIM31 is highly expressed in colonic and
intestinal epithelial cell lines. The expression of TRIM31 was analysed by RT-PCR (a) or immunoblot analysis (b) in various human cell lines: SW480
(colon), HT-29 (colon), and Caco-2 (intestine), A549 (lung), HeLa (cervix), U937 (lymphocyte), MCF-7 (breast), HFF (ﬁbroblast), JEG-3 (placenta), 293T
(embryonic kidney), Caki-2 (kidney) and AGS (stomach). Graph in a, quantiﬁcation of TRIM31 mRNA levels normalized against GAPDH (mean±s.d.).
(c) TRIM31 is enriched in the mitochondria. Immunoﬂuorescence assay (IFA) of HeLa cells transfected with TRIM31-Myc. Cells were immunostained with
anti-Myc antibody (green) and anti-TOM20 antibody (red), followed by AlexaFluor 488- or AlexaFluor 568-conjugated antibodies. TOM20 serves as
mitochondrial marker. Scale bar, 5 mm. (d) Mitochondrial localization of TRIM31-Myc. Cytosolic and mitochondrial fractions were isolated from TRIM31-
Myc-expressing HeLa cells, and then subjected to immunoblot analysis using anti-Myc antibody. Anti-TOM20 and anti-Tubulin antibodies were used to
designate the mitochondrial and cytoplasmic compartments, respectively. (e) TRIM31 is associated with the mitochondrial membrane. Isolated
mitochondria from TRIM31-Myc-expressing HeLa cells were treated with 0.1M NaCl or 0.1M Na2CO3 (pH 11.5) for 20min on ice. After centrifugation, the
supernatant (S) and pellet (P) were analysed by immunoblotting using anti-TRIM31 and anti-TOM20 antibodies. (f) Representative immunohistochemical
analysis of human TRIM31 on tripled Crohn’s disease (CD #1, #2, #3) and adjacent normal tissues from colon cancer (Con#1, #2, #3). The ileal mucosa
biopsies of the distal small intestine from normal or Crohn’s disease patients were stained with anti-TRIM31 antibody. Scale bars, 100mm. Right graph,
Immunohistochemical score (IHS) of TRIM31 in normal (n¼ 3) or Crohn’s disease patients (n¼ 8). Detailed patient information is presented in
Supplementary Table 2. IHS was equal to the quantity scores multiplied by the staining intensity scores. *Po0.01 (Student’s t-test). (g) TRIM31 mRNA
levels were determined by RT-PCR on tripled Crohn’s disease (CD #1, #2, #3) and adjacent normal tissues from colon cancer (Con#1, #2, #3).
(h) TRIM31 mRNA levels were normalized against GAPDH in the graph. *Po0.01 (Student’s t-test). All data are representative of at least three
independent experiments (mean±s.d. in f,h).
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autophagic membranes also contain TRIM31. We fractionated
TRIM31- or autophagy-related proteins-expressing cells and these
proteins were recovered in the pellet and soluble fractions. As
reported previously28,29,33–35, the level of Atg7, Atg12, Atg5 and
LC3 were highly enriched in the pellet fractions (Fig. 2e). In a
similar way, this separation resulted in the exclusive partitioning of
TRIM31 to the pellet fractions (Fig. 2e, ﬁrst panel). In addition,
these isolated pre-autophagic membranes also contained
mitochondria derived, but not cytoplasm-derived markers,
suggesting that the autophagic membranes originating from
mitochondria contain TRIM31. In particular, the amount of LC3
and TRIM31 proteins gradually decreased in the pellet after 3 h of
starvation, possibly due to autolysosomal degradation during
autophagy process (Fig. 2e, ﬁrst and ﬁfth panels). To test this, we
administered chloroquine to TRIM31-Myc-expressing cells and
examined the level of TRIM31 expression. As expected, substantial
TRIM31 accumulation was observed in the pellet of chloroquine-
treated cells (Fig. 2f; Supplementary Fig. 2c), Taken together, these
ﬁndings suggest that TRIM31 is involved in the autophagy process.
TRIM31 promotes autophagy induced by LPS. We then
proceeded to clarify whether TRIM31-containing puncta indeed
constitute an autophagic structure that subsequently fuses with
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Figure 2 | Human TRIM31 induces autophagy. (a) Starvation enhances colocalization of endogenous TRIM31 and LC3 in the intestinal epithelial cell line,
Caco-2. Cells were incubated with complete media (-starvation) or serum-free DMEM for 6 h, immunostained with anti-TRIM31 and anti-LC3 antibodies, and
then analysed by confocal microscopy. Scale bars, 5mm. (b) TRIM31-Myc (red) colocalizes with GFP-LC3 (green) and accumulates LC3-positive puncta in
HeLa cells. TRIM31-Myc was stained using anti-Myc antibody and analysed by IFA. Blue, DAPI. Scale bars, 5mm. Right graph, quantiﬁcation of LC3 puncta in
HeLa cells expressing either Mock or TRIM31-Myc. *Po0.01 (Student’s t-test). (c) Overexpressed TRIM31-Myc upregulates LC3-II in HeLa (upper panels) and
HEK293T (bottom panels) cells. HeLa cells were starved in serum-free DMEM for 8 h and then subjected to immunoblot analysis with the indicated antibodies.
(d) The LC3-II band intensities in c were quantiﬁed by scanning densitometry and normalized to the b-actin or tubulin band intensity. *Po0.01 (Student’s t-
test). (e) Starvation leads to the enrichment of autophagosomal components in the pellet fraction of HeLa cells. HeLa cells were transfected with plasmids
expressing TRIM31-Myc, Myc-Atg7, HA-Atg12, Atg5-HA or EGFP-LC3 and then starved in serum-free DMEM for the indicated times. Cells were separated
into soluble and pellet fractions by centrifugation, and then subjected to immunoblot analysis with the indicated antibodies. TOM20 and Tubulin were used to
indicate the mitochondrial and cytoplasmic compartments, respectively. (f) TRIM31-Myc-expressing HeLa cells were starved in serum-free DMEM and then
incubated with chloroquine. Cells were lysed with 1% NP-40 and separated into soluble and pellet fractions by centrifugation. Samples were subjected to
SDS–PAGE and detected with primary antibodies as indicated. All data are representative of at least two independent experiments (mean±s.d. in b,d).
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lysosomes to form autolysosomes. To accomplish this, we used
tandem green ﬂuorescent protein (GFP) and red ﬂuorescent
protein (RFP)-tagged LC3 and TRIM31 fusion proteins. Whereas
GFP is sensitive to acidic conditions, monomeric RFP is resistant
to both acid and lysosomal proteases. These properties allow the
red and green ﬂuorescence of mRFP-GFP-LC3 to be sustainable
and transient, respectively, thereby providing us with a valuable
tool for monitoring the maturation process from autophagosome
to autolysosome36,37. In particular, because lipopolysaccharide
(LPS) derived from the cell wall of Gram-negative bacteria
induces autophagy38,39, we assessed LPS-mediated autolysosomal
formation to understand the functional role of human TRIM31
in intestinal epithelial autophagy. Yellow puncta, reﬂective of
combined GFP and RFP ﬂuorescence, represent autophagosomes,
whereas red puncta represent autolysosomes whose acidic pH
quenches GFP ﬂuorescence. Under LPS-stimulated conditions, an
increase in the red signal of LC3 was observed with the yellow
signal (Supplementary Fig. 3a,b). Remarkably, TRIM31 RFP
signals were signiﬁcantly increased in LPS-stimulated cells,
indicating that incorporation of TRIM31 into autolysosomes
was increased in response to LPS (Fig. 3a,b).
We further examined whether the formation of TRIM31-
positive autolysosomes shares the E3-like enzyme, Atg5–Atg12,
similar to the conventional autophagy process. As previously
reported in many studies, Atg5 / mouse embryonic ﬁbroblasts
(MEFs) failed to form autolysosomes, whereas LC3-containing
autolysosomes developed in control cells (Fig. 3c). Surprisingly,
Atg5 / cells demonstrated formation of numerous
TRIM31-positive autophagosomes under normal conditions.
Moreover, following LPS stimulation, a signiﬁcant increase in
red signal was observed with little decrease in the yellow signal
(Fig. 3d,e). TRIM31 expression was also signiﬁcantly increased in
Atg5 / cells, especially in the pellet fractions, indicating that
TRIM31-mediated autophagy may compensate for the loss of
Atg5 in the conventional process by inducing TRIM31 expression
(Fig. 3f). Furthermore, while TRIM31-associated red dots
colocalized with LC3 in the absence of LPS, large numbers of
TRIM31 RFP signal did not overlap with LC3 in LPS-stimulated
cells (Fig. 3g, arrowheads). Taken together, these results suggest
that TRIM31 can induce autolysosomes via an Atg5-independent
alternative autophagic pathway.
To examine the localization of TRIM31 precisely, we carried
out immune-electron microscopy (EM) using an anti-Myc
antibody. Because most studies use an overexpression system to
visualize the subcellular localization of autophagic components by
EM, we generated Atg5 / cells, which stably expressed
TRIM31-Myc. However, we failed to maintain a high enough
level of TRIM31 expression in LPS-treated cells since we
observed a rapid degradation of TRIM31 in LPS-exposed cells
(Supplementary Fig. 4a). Although this degradation was
attenuated by chloroquine, it was not sufﬁcient for the optimal
expression levels of TRIM31. Thus, we hypothesized that TRIM31
may degrade in a proteasome-dependent manner together with
autolysosomes during LPS stimulation because TRIM31 belongs
to the TRIM family, which contributes to degradation of target
proteins through ubiquitination21. Indeed, TRIM31 degradation
was inhibited by the proteasome inhibitor, MG132, indicating
that TRIM31 may undergo ubiquitination itself, leading to
proteasome-dependent degradation (Supplementary Fig. 4b).
To test this hypothesis, we generated a TRIM31 deletion
mutant lacking the RING domain (Supplementary Fig. 4c).
Compared with wild-type TRIM31, the deletion mutant abolished
the auto-ubiquitination activity that leads to prolonged TRIM31
expression (Supplementary Fig. 4d). In addition, this mutant
did not affect TRIM31-positive autophagic formation or
phosphatidylethanolamine (PE) interaction, as seen with
wild-type TRIM31 (Supplementary Fig. 4e,f); this result enabled
us to maintain a high level of TRIM31 expression in
LPS-stimulated Atg5 / cells for observing its subcellular
localization by EM. Notably, TRIM31 was clearly observed
in typical double-membrane autophagic structures in LPS-
stimulated Atg5 / cells with chloroquine, as TRIM31 RFP
signals increased signiﬁcantly in LPS-stimulated cells (Fig. 3h).
Furthermore, we observed an approximately twofold increase
in the total number of autophagic vesicles in LPS-stimulated
Atg5 / cells expressing TRIM31 compared with untreated cells
(Fig. 3i). Therefore, we conclude that TRIM31 promotes LPS-
dependent autophagy in an Atg5-independent alternative process.
TRIM31 interacts with PE independently of Atg7. Mitochondria
are a primary source of membranes, where phosphatidylserine is
converted to PE by the mitochondrial enzyme phosphatidylserine
decarboxylase26. Additionally, since LC3 conjugation to PE is
essential for membrane tethering and isolated membrane
expansion during autophagosome formation40,41, we
hypothesized that mitochondria-localized TRIM31 may directly
interact with PE for autolysosome formation. To test this, we
treated cells with 80% 18:1–16:0 PC (1-oleoyl-2-palmitoyl-sn-
glycero-3-phosphocholine) and 20% 18:1–12:0 nitrobenzosadiazole
(NBD)–PE (1-oleoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)
amino]dodecanoyl}-sn-glycero-3-phosphoethanolamine), a ﬂuo-
rescent analogue of PE, and then assessed NBD–PE localization.
The ﬂuorescent signal of NBD–PE was observed in the
endoplasmic reticulum membrane early after cell loading and
subsequently within mitochondrial membranes (Supplementary
Fig. 5a). In cells expressing LC3-Gly, in which the C-terminal
glycine residue was exposed, NBD ﬂuorescence clearly appeared in
LC3-Gly-positive autophagosomal puncta, suggesting that NBD–
PE can transfer from mitochondria to autophagosomes (Fig. 4a,
upper panel). Interestingly, a strong signal in NBD–PE also
overlapped with TRIM31 (Fig. 4a, lower panel). In addition,
colonic epithelial cells clearly exhibited colocalization of TRIM31
with NBD–PE (Fig. 4b). To further determine how each domain
contributes to TRIM31–PE colocalization, we generated truncated
forms of Myc-tagged TRIM31 (Supplementary Fig. 5b). Both
TRIM31DN and TRIM31DC still formed TRIM31-positive puncta
that overlapped with NBD–PE in a similar manner as wild-type
TRIM31. Surprisingly, TRIM31DBB was only distributed
throughout the cytoplasm and therefore failed to form a
punctate structure with NBD–PE (Supplementary Fig. 5c). These
ﬁndings suggest that the B-box domain is required for the
formation of TRIM31-positive puncta and colocalization with PE.
To analyse the direct interaction between TRIM31 and PE, we
used a liposome-based cell-free system that enables chemical
interaction of TRIM31 to PE lipids, thus bypassing the
requirement for any conjugation machinery42. This system is
based on a crosslinking reaction between substrates and the
PE lipid. Notably, TRIM31 interacted with PE but not
sphingosine as demonstrated by measuring the NBD
ﬂuorescence signal in the presence of crosslinker (AMAS)
(Fig. 4c). To support these results, we performed a protein-lipid
overlay assay, as described previously43,44. Indeed, TRIM31
bound strongly to PE but not 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphocholine (POPC; Fig. 4d). Collectively, these results
suggest that TRIM31 speciﬁcally interacts with PE.
Since studies have established that LC3 lipidation is mediated
by an amide bond between the exposed C-terminal glycine
and the amine group of PE33, we examined whether TRIM31 is
covalently conjugated to PE. We found that TRIM31
possesses two glycines, which are highly conserved across
species (Supplementary Fig. 6a). To test whether glycine
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residues on TRIM31 are involved in PE interaction, we
constructed two truncation mutants, TRIM31-110G and
TRIM31-163G, in which the glycine residues were made
available for covalent coupling with PE (Supplementary
Fig. 6b). Our examination revealed that these mutants were
distributed throughout the nucleus or cytoplasm and failed to
detect any punctate structures in a similar pattern as
TRIM31DBB (Supplementary Fig. 6c), suggesting that the
TRIM31–PE interaction is not mediated by glycine-dependent
covalent binding.
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All data are representative of at least two independent experiments (mean±s.d. in b,e and i).
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We also determined whether the TRIM31–PE interaction is
mediated by the E1-like enzyme, Atg7, which participates in the
conventional autophagy process. In the case of LC3, binding to
PE was observed in control cells, whereas this interaction was
absent in Atg7 / cells, due to failure to form LC3-positive
autophagosomes (Supplementary Fig. 7a). We have previously
shown that Atg5 / cells form numerous TRIM31-mediated
autophagosomes/autolysosomes (Fig. 3). Notably, the TRIM31–
PE interaction was clearly observed in Atg7 / cells (Fig. 4e).
We also examined TRIM31–PE binding in HT-29 cells lacking
Atg7, Beclin1, or LC3. As expected, TRIM31 clearly bound to PE,
even in the absence of canonical autophagy-related proteins
(Supplementary Fig. 7b). Therefore, mitochondrial TRIM31 can
directly interact with PE, thereby enabling autolysosome
formation, independent of the conventional autophagy pathway.
Palmitoylation is involved in autophagy mediated by TRIM31.
TRIM31 is located within a double-membrane structure of the
autophagosome even though it does not possess a membrane-
spanning domain. Although we noted that TRIM31 interacts
directly with PE, we also considered the involvement of other
lipid modiﬁcations on TRIM31, such as myristoylation,
prenylation and palmitoylation that acquire more sufﬁcient
hydrophobicity for membrane association and exclusive
partitioning in the pellet fractions similar to LC3, Atg5, Atg7 or
Atg12. In particular, recent studies showed that palmitoylation is
critical for membrane association by immunity-related GTPase
family M protein, which plays a role in autophagy and
the reduction of intracellular bacteria45–47. We did not
observe any well-deﬁned consensus sequences for
myristoylation or prenylation on TRIM31. Interestingly,
bioinformatics analysis48–50 identiﬁed potential palmitoylated
cysteine residues within the B-box region, which are highly
conserved across various species (Fig. 5a).
Because palmitoylation occurs on cysteines, we constructed a
point mutant by substituting cysteines with alanines. Then we
assessed its puncta pattern in comparison to wild-type TRIM31.
Notably, unlike wild-type TRIM31, this mutant was distributed in
the cytosol and nucleus and we failed to observe puncta staining
similar to TRIM31DBB (Supplementary Fig. 8a). We next
examined whether TRIM31-AXXA is capable of crosslinking
with PE. Strikingly, the NBD ﬂuorescence signal of the TRIM31-
AXXA mutant was considerably reduced at B80% (Fig. 5b,
lane 5), indicating that cysteine residues within the TRIM31
B-box are critical for PE binding in vitro. Because this in vitro
crosslinking experiment does not represent a direct involvement
of palmitoylation on TRIM31-mediated autophagy process, we
further explored whether TRIM31-AXXA mutant directly affects
autophagy maturation in cells. Notably, this mutant failed to
overlap with PE and punctate structures of LC3 in cells similar
to TRIM31DBB (Fig. 5c; Supplementary Fig. 8b). In contrast to
Merge
Merge
GST-TRIM31-WT
GST-TRIM31-WT
NBD-PE
GST-TRIM31-WT
GST-TRIM31-WT
NBD-labeled
liposomes
NBD-SP
–AMAS
POPC PE
(kDa)
25
20
20
15
10
5
0
25
15
25
10
–
–
–
–
+
+
+
+
N
BD
At
g7
–
/–
At
g7
+
/+
At
g7
+
/+
At
g7
–
/–
Atg7 +/+
Atg7 –/–
Co
om
as
sie
N
um
be
r o
f T
R
IM
31
 p
un
ct
a
co
lo
ca
liz
e
d 
wi
th
 N
BD
-P
E 
pe
r c
el
l
+AMAS
Merge
NBD-PE
NBD-PE
M
yc
-L
C3
-G
ly
TR
IM
31
-M
yc
α-Myc
α-GST
α-TRIM31
TRIM31
HeLaa
b
c
e
d
HT-29
NBD-PE
Enlarged
Figure 4 | TRIM31 interacts with PE in an Atg7-independent manner. (a) Colocalization of NBD–PE with TRIM31-Myc in HeLa cells. Intracellular NBD–PE
labelling using delivery of liposomes consisting 80% 18:1–16:0 PC and 20% 18:1–12:0 NBD–PE. Cells were exposed to liposomes, washed with PBS, and
maintained in complete media for 2 h. The C-terminal glycine-exposed form of LC3, Myc-LC3-Gly, was used as a positive control. (b) Colocalization of
NBD–PE with endogenous TRIM31 in HT-29 cells. Cells were exposed to NBD–PE liposomes and ﬁxed. Cells were then immunostained with an anti-TRIM31
antibody. Scale bars, 5 mm. (c) Crosslinking experiment of puriﬁed GST-tagged TRIM31-wild-type B-Box (GST-TRIM31-WT) with liposomes consisting of
20% NBD–PE/80% POPC or 20% NBD-sphingosine/80% POPC. Liposomes were incubated with the cross-linker AMAS (0.5mM), and then glycine was
added to terminate the crosslinking reaction. GST-TRIM31-WTwas added to the reaction buffer, and sample reactions were terminated with the addition of
5 SDS loading buffer. The LAS image analyser was used to detect NBD ﬂuorescence (upper) while Coomassie blue staining was used to visualize protein
levels (bottom). (d) The ability of the GST-tagged TRIM31-wild-type B-Box (2mgml 1) to bind PE or POPC was analysed by a protein-lipid binding assay
on nitrocellulose. Nitrocellulose membranes were spotted with 100pmol of phospholipid. (e) TRIM31-Myc colocalizes with NBD–PE in puncta independent
of Atg7. Wild-type or Atg7 / cells stably expressing TRIM31-Myc were labelled with liposomes containing 20% NBD–PE and 80% PC and chased in
complete media for 1 h, followed by immunostaining with anti-Myc antibody. Scale bars, 5 mm. Quantiﬁcation is shown in the right graph (mean±s.d.). All
data are representative of at least three independent experiments.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11726 ARTICLE
NATURE COMMUNICATIONS | 7:11726 | DOI: 10.1038/ncomms11726 | www.nature.com/naturecommunications 7
wild-type TRIM31, the expression of TRIM31-AXXA failed to
detect a signiﬁcant induction of LC3-II accumulation in
HEK293T and HeLa cells (Supplementary Fig. 8c,d). Further-
more, we did not observe RFP signals from TRIM31-AXXA,
indicating that these cysteine residues are critical to the induction
of TRIM31-mediated autophagy (Fig. 5d). To examine whether
the observed failure of the TRIM31-AXXA-PE interaction was
not due to lack of access to PE as a result of disrupted subcellular
targeting of the mutant to mitochondria, we performed
subcellular fractionation for mitochondria and cytosol. Similar
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to wild-type TRIM31, TRIM31-AXXA was targeted to mitochon-
dria (Supplementary Fig. 8e).
To further address whether palmitoylation is indeed involved in
TRIM31-mediated autophagy activation, we exposed wild-type
TRIM31-expressing cells to the palmitoylation-speciﬁc inhibitors,
2-bromopalmitic acid (2-BP) and tunicamycin, which are broadly
used for inhibiting subcellular palmitoylation processes51–54.
Markedly, wild-type TRIM31 failed to form a punctate structure
in cells exposed to both inhibitors in a manner similar to
TRIM31DBB or TRIM31-AXXA (Fig. 5e; Supplementary Fig. 8f).
Moreover, 2-BP signiﬁcantly affected TRIM31–PE binding and
autolysosomal formation since a reduction in ﬂuorescent signals of
NBD–PE and RFP was observed (Fig. 5f,g). Taken together, these
ﬁndings demonstrate that palmitoylation is essential for PE
interaction with TRIM31, thus promoting autophagic membrane
association and autolysosomal formation.
Autophagy induced by TRIM31 inhibits invasive bacteria.
Because TRIM31 can form autophagosomes/autolysosomes and
LPS promotes TRIM31-mediated autolysosome formation, we
speculated that intestine-speciﬁc TRIM31 may inhibit the survival
of invasive bacteria by activating autophagy in the intestinal cells.
Shigella ﬂexneri are Gram-negative bacteria that are highly
pathogenic for humans55–57. To investigate whether Shigella
would be taken up into TRIM31-positive autophagosomes, we
infected GFP-labelled pathogenic wild-type S. ﬂexneri (M90T
strain) into intestinal epithelial cells. We observed extensive
colocalization of endogenous TRIM31 with Shigella and
accumulation of TRIM31 around the surface of Shigella in
intestinal and colonic cells (Fig. 6a; Supplementary Fig. 9a).
In particular, NDP52 recognizes ubiquitin-coated Salmonella and
Shigella, thus recruiting LC3 and activating autophagy58. To
address whether this accumulation was due to the speciﬁc
interaction of TRIM31 with the receptor recognizing ubiquitin-
coated bacteria, we next examined the binding of TRIM31 with
NDP52. Our data showed a considerable interaction between
TRIM31 and NDP52 (Fig. 6b), suggesting that NDP52 recruits
Shigella into TRIM31-positive autolysosomes.
These results led us to investigate whether TRIM31 is indeed
required to restrict the growth of Shigella in epithelial cells. To
test whether autophagy is involved in restricting Shigella growth,
we ﬁrst investigated the colocalization of Shigella with lysosomes
and measured the rate of bacterial growth in chloroquine-treated
cells. As expected, Shigella clearly colocalized with lysosomes
similarly to TRIM31 and autolysosomal inhibition enhanced the
proliferation of Shigella (Fig. 6c; Supplementary Fig. 9b). Notably,
TRIM31 depletion also led to dramatic hyperproliferation of
Shigella. In fact, the kinetics and magnitude of Shigella growth
were very similar between HT-29 cells that were depleted of LC3
and TRIM31 (Fig. 6d). In addition, the Shigella survival rate in
intestinal cells lacking both LC3 and TRIM31 was much higher
than that in cells with depleted of LC3 or TRIM31 alone (Fig. 6e).
Furthermore, expression of TRIM31-AXXA partially decreased
Shigella growth (Fig. 6f). This partial effect might be due to
endogenous LC3 expression in HeLa cells. These data suggest that
TRIM31-induced autophagy is essential for restricting the growth
of Shigella in epithelial cells.
We previously showed that TRIM31 induces LPS-induced
alternative autolysosome formation (Fig. 3). In addition, TRIM31
clearly colocalized with PE even in HT-29 cells lacking Atg7,
Beclin1 or LC3 (Fig. 4e; Supplementary Fig. 7b). Similarly, we
observed extensive colocalization of endogenous TRIM31 with
Shigella in HT-29 cells depleted of Atg7, Beclin1 or LC3
(Supplementary Fig. 9c). We thus sought to examine whether
TRIM31-mediated autophagy promoted bacteria elimination via
an alternative autophagy pathway. Because canonical autophagy
is known to be essential for eliminating intracellular bacteria,
when Atg7 / cells were infected with Shigella, Atg7-deﬁcient
cells failed to clear bacteria, thus severely increasing the bacterial
load. Interestingly, introduction of TRIM31 into Atg7 / cells
restored their ability to clear Shigella (Fig. 6g). Furthermore, a
large amount of Shigella colocalized with TRIM31 rather than
LC3 (Fig. 6h; Supplementary Fig. 9d). Taken together, TRIM31
induces alternative autophagy, which is essential for eliminating
intracellular pathogenic Shigella in intestinal cells.
Antibacterial effect requires control of TRIM31 expression.
Invasive bacteria activate intestinal epithelial autophagy59. Thus,
we proposed that invasive bacteria might elicit a high level of
TRIM31 expression, thus promoting intestinal autophagy to
maintain immune homoeostasis. To explore this hypothesis,
HT-29 cells were infected with Shigella and then TRIM31
expression was examined by reverse transcription (RT)-PCR.
Remarkably, the invasive Shigella elicited enhanced TRIM31 gene
expression (Fig. 7a). Since Toll-like receptor 4 (TLR4) recognizes
LPS, which controls autophagy as a sensor38,39, we examined the
effect of LPS on the activation of TRIM31 gene expression.
TRIM31 mRNA was markedly increased in a time-dependent
manner (Fig. 7b), suggesting that LPS-mediated TLR4 signalling
is involved in eliciting TRIM31 gene expression to activate
alternative autophagy and regulate intestinal homoeostasis.
Because TRIM31 is mainly expressed in the intestine, we did
not observe TRIM31 expression in HeLa cells, which normally
express LC3. Interestingly, when HeLa cells were treated with
LPS, we clearly observed TRIM31 expression at 3 h post
stimulation (Fig. 7c). Furthermore, we observed recruitment of
Shigella into TRIM31-positive autophagosomes in HeLa cells
similar to intestinal epithelial cells (Supplementary Fig. 9e).
Additionally, since it is known that Shigella invades HeLa cells
with high efﬁciency, bacteria-induced apoptosis readily occurs in
a caspase-1-dependent manner60,61. Thus, we hypothesized that if
Shigella is not efﬁciently eliminated by autophagy activation,
HeLa cells may be more susceptible to apoptosis following robust
bacterial growth. To test this, we evaluated the degree of apoptosis
in Shigella-infected HeLa cells that expressed an empty vector or
TRIM31 by using propidium iodide staining. Indeed, Shigella
clearly induced apoptosis (Fig. 7d). Markedly, in TRIM31-
overexpressing HeLa cells, the level of apoptosis was
considerably decreased, indicating that a TRIM31-dependent
alternative autophagy is essential to block disseminating
intracellular Shigella in HeLa cells, thus protect against bacteria-
induced apoptosis.
To understand the physiological relevance of human TRIM31-
induced alternative autophagy in intestinal epithelial cells, we
utilized a human cytomegalovirus (HCMV) system. Because
HCMV can infect the gastrointestinal tract, the prevalence of
active HCMV infection in the colon is signiﬁcantly higher in
patients with IBD relative to controls, suggesting that IBD
severity correlates positively with HCMV infection62–65.
However, it remains unknown how HCMV infection affects
IBD severity. Since we previously showed an aberrant low-level
expression of TRIM31 in patients with Crohn’s disease
(Fig. 1f–h), we speculated that HCMV infection affects TRIM31
expression in intestinal epithelial cells. We infected the intestinal
epithelial cell line Caco-2 with the wild-type HCMV strain
AD169 and then examined endogenous TRIM31 expression.
Remarkably, HCMV infection unambiguously downregulated
endogenous TRIM31 expression in a dose-dependent manner,
but not LC3 (Fig. 7e,f). A recent study showed a signiﬁcant
mucosal HCMV viral load in IBD patients relative to control
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populations66. To further determine whether the proliferation of
Shigella is affected by HCMV infection, intestinal cells were
infected with HCMV, followed by infection with Shigella before
measuring the degree of bacterial growth. Interestingly, HCMV-
infected intestinal cells showed a signiﬁcant increase in bacteria
load (Fig. 7g). To determine whether this hyperproliferation of
Shigella in HCMV-infected cells is due to HCMV-mediated
TRIM31 downregulation, we introduced wild-type TRIM31 into
HCMV-infected intestinal cells and examined Shigella growth.
Surprisingly, introduction of TRIM31 markedly restored the
clearance of intracellular Shigella (Fig. 7g). This is consistent with
the observation that lack of TRIM31 disrupts autophagic
elimination of intracellular Shigella (Fig. 6). These results
demonstrate that HCMV leads to TRIM31 downregulation at a
later time during HCMV infection, reﬂecting the functional
relevance of HCMV infection on IBD severity.
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Discussion
Our ﬁndings suggest that the intestinal autophagy process is
considerably more complicated than previously thought and
involves an additional pathway that functions independently of
canonical Atg-mediated autophagy. The intestinal epithelium is a
highly specialized region that interfaces with a dense microbial
community, including non-pathogenic and pathogenic bacteria.
Thus, we hypothesize that this alternative autophagy pathway
functions along with the Atg5/7-dependent canonical autophagy
to both limit an overﬂow of commensal bacteria and eliminate
invasive organisms. Here, we report that intestine-speciﬁc
TRIM31 is able to interact with mitochondrial PE in both wild-
type and Atg7 / cells, thereby activating autophagosome
formation. TRIM31–PE binding induces an Atg5/7-independent
alternative autophagy pathway, which can eliminate invasive
pathogenic Shigella bacteria (Fig. 7h). Our data also indicate that
TRIM31-mediated non-canonical autophagy in the intestine can
compensate for the functional roles of canonical autophagy
following the loss of Atg proteins. Although both processes
lead to bacterial clearance in the intestine, their activities may be
appropriately balanced by protein expression and downstream
activation, and further, these pathways may function together to
promote healthy gut homoeostasis.
As noted previously, because TRIM31 is preferentially
colocalized with NBD–PE, we originally predicted that this
protein is conjugated with PE in vivo. Unfortunately, we failed to
observe TRIM31–PE conjugation in vivo following puriﬁcation of
TRIM31 and subsequent mass spectrometry. Similar to the
LC3-II puriﬁcation described by Kabeya et al.29, the absolute
amount of TRIM31 may be difﬁcult to determine due to
rapid degradation of this protein via self-ubiquitination and
autophagy-mediated lysosomal targeting (Supplementary Fig. 4).
Furthermore, in the study by Ichimura et al.33, which ﬁrst
demonstrated that Atg8 is covalently conjugated to PE using mass
spectrometry, the experiments were performed using yeast cells
in vitro, rather than live cells in vivo. Based on both these reports
and our trials, we may be confronted with a technical challenge in
determining the absolute TRIM31 yield after puriﬁcation or
elution from the gels. Additionally, in experiments with TRIM31
mutants containing glycine residues available for covalent
coupling with PE, the TRIM31 constructs were distributed
throughout the nucleus or cytoplasm, and we failed to detect
any punctate structures, similar to the pattern observed with
the TRIM31DBB or TRIM31-AXXA mutants (Supplementary
Fig. 6a–c). These results suggest that the TRIM31–PE interaction
is mediated by glycine-independent covalent binding.
Our data further suggest that palmitoylation of TRIM31 is
critical for this alternative autophagy pathway. Namely, we found
a signiﬁcant defect of punctate structure formation in cells
exposed to palmitoylation-speciﬁc inhibitors, and observed a
similar subcellular localization pattern in cells containing a
TRIM31-AXXA mutant, in which cysteine residues predicted to
function as potential palmitoylation sites were replaced with
alanines. However, we have been unable to show a direct
palmitoylation of TRIM31 at these cysteines. Of note, the B-box
of MuRF1 coordinates two zinc ions through highly conserved
cysteine residues67, assuming that these cysteines within the
B-box would be inaccessible for palmitoylation. However,
Gottlieb et al.68 suggested that the cysteine-rich domain of the
DHHC3 protein contains tightly bound zinc ions, which is
required for palmitoylation at the cysteine residues. Moreover,
mutation of the DHHC motif cysteine abolishes detectable
incorporation of palmitate and eliminates the steady state
palmitoylation of DHHC3 palmitoyltransferases. Similarly,
because TRIM31 consists of 12 cysteine residues in the RING
ﬁnger and B-box domains, other cysteines might be involved in
coordinating zinc ions, which may contribute to efﬁcient
palmitoylation at the cysteine residues within the TRIM31
B-box domain. Fairbank et al.69 also showed that the RING
ﬁnger domain of the GP78 ubiquitin ligase contains a conserved
series of cysteine residues and is palmitoylated at a speciﬁc subset
of these residues, and this modiﬁcation is critical for its
subcellular distribution to the peripheral endoplasmic
reticulum. In a similar context, it is possible that the RING
ﬁnger of TRIM31 may also be involved in palmitoylation,
which could have signiﬁcant implications for TRIM31-mediated
autophagy. In this regard, other cysteines in TRIM31 are
also plausible candidates for possible palmitoylation, potentially
functioning to promote interaction with PE and autophagy
induction.
TLRs recognize different components from bacteria, fungi and
viruses to promote various cytokines and chemokines that are
critical for inducing innate and adaptive immune responses70.
Because TLR4 is essential for LPS recognition, many adaptor
proteins involved in activating this receptor could also be critical
in LPS-induced TRIM31 gene expression and its modiﬁcation.
Particularly, TRIM31 is a member of RBCC proteins composed of
RING ﬁnger, B-box and coiled-coil domain. Consistent with
Sugiura and Miyamoto21, who reported that TRIM31 possesses
E2-selective ubiquitin ligase activity, our results showed
that TRIM31 regulates its expression levels via RING domain-
dependent auto-ubiquitination. It is possible that LPS-mediated
poly-ubiquitination of TRIM31 may occur at later times
after autophagy activation, thus preventing excessive TRIM31-
mediated alternative autophagy process and maintaining
intestinal homoeostasis.
As noted previously, HCMV infection in the colon is
considerably higher in patients with IBD relative to controls,
indicating that IBD severity correlates positively with HCMV
infection62–65. Based on our ﬁndings, HCMV targets
TRIM31 downregulation, resulting in hyperproliferation of
invasive bacteria. Thus, HCMV infection may be a risk factor
Figure 7 | HCMV infection abrogates TRIM31 expression. (a) Left, HT-29 cells were infected with invasive Shigella M90T strain. TRIM31 mRNA levels
were determined by RT-PCR. Right, Quantiﬁcation of TRIM31 mRNA levels normalized against GAPDH, which was used as a loading control. *Po0.01
(Student’s t-test). (b) HT-29 cells were treated with LPS (100ngml 1) for 0, 1 or 3 h, and then TRIM31 mRNA was measured by RT-PCR. Right,
Quantiﬁcation of TRIM31 mRNA levels normalized against GAPDH, which was used as a loading control. *Po0.01 (Student’s t-test). (c) TRIM31 mRNA
was measured by RT-PCR in HeLa cells treated with LPS (100 ngml 1) for 0, 1 or 3 h. *Po0.01 (Student’s t-test). (d) Cell death was assessed by propidium
iodide (PI) staining of mock or TRIM31-Myc-expressing HeLa cells infected with M90T-GFP followed by ﬂow cytometric analysis. Values represent the
average of three independent experiments. *Po0.05 (Student’s t-test). (e) HCMV infection down-regulates TRIM31 expression. Wild-type HCMVAD169
strain was infected into the intestinal epithelial cell line, Caco-2, for 48 h, and then HCMV immediate early gene (IE1), LC3, or TRIM31 mRNA was measured
by RT-PCR. (f) Quantiﬁcation of TRIM31 and LC3 mRNA levels normalized against GAPDH. *Po0.01 (Student’s t-test). (g) HCMV-infected intestinal cells
show a considerable increase in bacteria load. Intestinal cells were infected with HCMV for 48 h, followed by infection with Shigella prior to measuring the
degree of bacterial growth. TRIM31 or IE1 mRNA levels were determined by RT-PCR. Values represent the average number of colonies from three
independent experiments. *Po0.01 (Student’s t-test). All data are representative of at least three independent experiments (mean±s.d. in a–d, f–g).
(h) Proposed model of TRIM31-mediated alternative autophagy process in the intestinal epithelial cells.
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for developing severe IBD. This is the ﬁrst evidence for the
molecular and physiological effect of HCMV on hindering host
autophagy against pathogenic intestinal bacteria by targeting
TRIM31.
Methods
DNA constructs. The human TRIM31 cDNA was purchased from Origene
(#MHS6278-202756045; GE Healthcare, Marlborough, MA, USA) and subcloned
into the pLHCX vector (Clontech, Mountain View, CA, USA) using the 50-GCTA
AGCTTGCCACCATGGCCAGTGGGCAGTTTGTGAA-30 (HindIII-TRIM31;
forward) and 50-GCTAGATCTGCTTGAAGGAACCTTACAAAACCAAG-30
(BglII-TRIM31; reverse) primers. All human TRIM31-related constructs were
fused at the C terminus to Myc. N- or C-terminal deletion constructs tagged at the
C terminus with Myc (DN-Myc (61–425) and DC-Myc (1–293)) were generated by
PCR. The B-Box (DBB-Myc) or RING (DRING-Myc) deletion construct was
generated by overlap extension PCR with the indicated primer pairs. All primers
are listed in Supplementary Table 1. Human NDP52 cDNA was isolated by PCR
using the cDNA library from HeLa cells with the following primers: NDP52 for-
ward, 50-AATGTTAACGGATCCATGGAGGAGACCATCAAAGAT-30 ; reverse,
50- AATATCGATCTCGAGTCAGAGAGAGTGGCAGAAC-30 . All constructs
were cloned into the retroviral pLHCX (hygro) vector (Clontech, Mountain View,
CA, USA) and veriﬁed by sequencing. EGFP-LC3 (Addgene plasmid #11546) or
mRFP-GFP-LC3 (Addgene plasmid #21074) was kindly provided by Dr Karla
Kirkegaard (Stanford University, Palo Alto, CA, USA) or Dr Tamotsu Yoshimori
(Osaka University, Japan), respectively. HA-Atg12 (Addgene plasmid #22950) and
Atg5-HA (Addgene plasmid #22948) were kindly supplied by Dr Noboru
Mizushima (University of Tokyo, Japan), and Myc-Atg7 (Addgene plasmid
#24921) was kindly provided by Dr Toren Finkel (NIH, USA).
Reagents. Antibodies to anti-TOM20 (sc-11415, 1:2,000) and anti-GST (sc-459,
1:1,500) were purchased from Santa Cruz (Santa Cruz Biotechnology, Santa Cruz,
CA, USA). Anti-LC3B (#2775, 1:1,000) and anti-Myc (#2276, 1:2,000) antibodies
were obtained from Cell Signaling Technology (Danvers, MA, USA). Anti-TRIM31
(H00011074-B01, 1:500 and 12543-1-AP, 1:2,000) antibody was purchased from
Abnova (Taipei City, Taiwan) and Proteintech (Rosemont, IL, USA), and mouse
monoclonal anti-Tubulin (#G094,1:2,000) antibody was obtained from Applied
Biological Materials Inc. (Richmond, Canada). Anti-p62 (#GP62-C, 1:2,000) anti-
body was purchased from Progen Biotechnik (Heidelberg, Germany). LysoTracker
Red (#L-7528) and AlexaFluor 350-, AlexaFluor 488-, and AlexaFluor 568-con-
jugated antibodies were obtained from Life Technologies (Carlsbad, CA, USA).
Lipids, namely, 18:1–16:0 PC (1-oleoyl-2-palmitoyl-sn-glycero-3-phosphocholine,
#850475), NBD-Sphingosine omega ((7-nitro-2-1,3-benzoxadiazol-4-yl)(2S,3R,4E)-
2-aminooctadec-4-ene-1,3-diol, #810205), and 18:1–12:0 NBD–PE (1-oleoyl-2-{12-
[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphoetha-
nolamine, #810156) were purchased from Avanti Polar Lipids (Alabaster, AL, USA).
Gentamicin sulfate salt (#G1264) and 2-Bromopalmitic acid (#238422) were
obtained from Sigma-Aldrich (St Louis, MO, USA). The S. ﬂexneri strain, invasive
M90T-GFP was kindly provided by Dr Dong Wook Kim (Hanyang University,
South Korea).
Cell culture and transfection. Human embryonic kidney (HEK) 293T cells (CRL-
3216, ATCC, Manassas, VA, USA), human foreskin ﬁbroblast (HFF) cells (SCRC-
1041, ATCC), the breast cancer cell line MCF-7 (HTB-22, ATCC), cervical cancer
cell line HeLa (CCL-2, ATCC), kidney carcinoma cell line Caki-2 (HTB-47, ATCC),
trophoblast cell line JEG-3 (HTB-36, ATCC), gastric cancer cell line AGS
(CRL-1739, ATCC), lung cancer cell line A549 (CCL-185, ATCC), colonic epithelial
cell line SW480 (CCL-228, ATCC), intestinal epithelial cell line Caco-2 (HTB-37,
ATCC), and MEFs (SCRC-1008, ATCC) were cultured in Dulbecco’s modiﬁed Eagle
medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum
(HyClone, Logan, UT, USA) and penicillin/streptomycin (HyClone). The colonic
epithelial cell line HT-29 (HTB-38, ATCC) and monocytic cell line U937
(CRL-1593.2, ATCC) were cultured in RPMI containing 10% heat-inactivated fetal
bovine serum and penicillin/streptomycin. Normal intestinal epithelial cells, FHs74
(CCL-241, ATCC) were cultured in Hybri-Care Medium ATCC 46-X supplemented
with 30ngml 1 epidermal growth factor (EGF) and 10% fetal bovine serum.
Tet-regulated Atg5 / or Atg7 / MEF cells were kindly provided by Dr
Mizushima or Dr Komatsu, respectively. Tet-regulated Atg5 / MEF cells were
maintained in complete DMEM with or without 10ng ml 1 doxycycline hyclate
(Sigma-Aldrich). Cells were transfected using Omicsfect (OmicsBio, Taipei City,
Taiwan) in serum-free and antibiotic-free DMEM for 30–36 h. All cells were grown
at 37 C in humidiﬁed air with 5% CO2.
Retroviral transduction and RNAi production. HEK293T cells were transfected
with plasmids encoding VSV-G and Gag-Pol, as well as shRNA for GFP (control),
TRIM31, LC3B, Atg7 or Beclin1. At 48 h post-transfection, media containing viral
particles were collected, ﬁltered through a 0.45-mm membrane, and then incubated
with cells for 24 h. Cells were selected with puromycin. The shRNA sequences were
subcloned into the pSUPER retroviral vector (Oligoengine, Seattle, WA, USA).
All oligomer sequences are listed in Supplementary Table 1.
RT-PCR. Total cellular RNA was isolated using an RNA prep kit (GeneAll, Seoul,
South Korea). RNA (0.5 mg) was reverse transcribed for 1 h with oligo dT at 42 C
using Moloney Murine Leukemia Virus (M-MLV) reverse transcriptase (Enzy-
nomics, Daejeon, South Korea). All primer sequences are listed in Supplementary
Table 1. Detailed CD patient information is included in Supplementary Table 2
NBD–PE formulation and labelling. To prepare liposomes, 80% PC and 20%
NBD–PE were mixed from stocks dissolved in chloroform. After transfer to a glass
tube, the chloroform solvent was removed by rotary evaporation for 1 h. Samples
were dried further in a desiccator under vacuum for 12 h. The resulting lipid ﬁlm was
suspended in a buffer (25mM Tris-HCl, pH 7.5, 137mM NaCl, 2.7mM KCl) at a
ﬁnal concentration of 1mM phospholipids by vortexing at room temperature.
Samples were then subjected to sonication for 5min to obtain small unilamellar
liposomes. Samples were added to cells at a 0.15mM concentration for 1–2 h to label
the cells. Cells were washed with warm PBS and incubated in DMEM or RPMI
supplemented with 10% FBS/penicillin/streptomycin for 1–2 h. After washing with
PBS, cells were ﬁxed in 3.7% formaldehyde, permeabilized with 0.1% Triton X-100
for 1min, and incubated with primary antibodies overnight at 4 C. Cells were
washed three times with PBS and incubated with the appropriate AlexaFluor
568-conjugated secondary antibody (1:200, Life Technologies). DAPI (40, 6-diami-
dino-2-phenylindole; Sigma-Aldrich) was used as a nuclear counterstain. Images
were collected using a confocal microscope (LSM 700, Carl Zeiss, Jena, Germany).
Coimmunoprecipitation and immunoblotting. Cells were lysed with 0.5% NP-40
in PBS supplemented with protease inhibitors for 1 h at 4 C. After pre-clearing lysates
with protein G-Sepharose (Sigma-Aldrich), primary antibodies and then protein
G-Sepharose were added to the supernatants and incubated at 4 C. The protein
G-Sepharose beads were washed three times with 0.1% NP-40/PBS. Proteins were
eluted from the beads by boiling in 2 Denature buffer (50mM Tris-HCl, pH 6.8,
2% SDS, 5% b-mercaptoethanol). Proteins were separated by SDS–polyacrylamide gel
electrophoresis (SDS–PAGE), transferred onto a polyvinyl diﬂuoride (PVDF) mem-
brane (Millipore, Billerica, MA, USA), and probed with the appropriate antibodies
overnight at 4 C. Membranes were washed three times with PBS containing 0.1%
Tween-20 and incubated with horseradish peroxidase-conjugated secondary anti-
bodies for 1 h at room temperature. The immunoblots were visualized with enhanced
chemiluminescence detection reagents (Advansta, Menlo Park, CA, USA). Uncropped
images of western blots are shown in Supplementary Fig. 10.
Infection and bacterial assays. S. ﬂexneri M90T-GFP was grown overnight in LB
broth and subcultured (1:10) for 6 h before infection. After collection by
centrifugation, bacteria were resuspended in warm PBS using the same volume of
LB broth. Then, the bacterial solution was added to cells in 24-well plates. Plates
were centrifuged for 10min at 670g. After incubation at 37 C for 20min, cells were
washed twice with warm PBS and then incubated in 100 mgml 1 gentamicin for
the duration of the experiment to count intracellular bacteria. Cells from triplicate
wells were lysed in PBS containing 0.1% Triton X-100 and plated in duplicate onto
agar plates containing ampicillin. For the immunoﬂuorescence assays, M90T-GFP-
infected cells were washed twice with warm PBS and incubated in 100 mgml 1
gentamicin for 30min. Lysosomes were labelled by incubating cells with
Lysotracker Red for 30min during their incubation with bacteria.
Immunohistochemistry. Formalin-ﬁxed parafﬁn-embedded tissue sections
(adjacent normal tissues from cancer patients and inﬂamed tissues from Crohn’s
patients operated for colon) were stained for anti-TRIM31 antibody (1:100) and
counterstained with hematoxylin. To quantify TRIM31 expression, we studied ﬁve
randomly selected 0.159-mm2 ﬁelds for each sample at  100 magniﬁcation and
scored range from 0 to 3. Detailed CD patient information is included in
Supplementary Table 2.
Immunoelectron microscopy. Cells were ﬁxed in a mixture of 2% formaldehyde
and 0.1% glutaraldehyde in 0.1M cacodylate buffer (pH 7.2) for 30min at 37 C
initially, rinsed with buffer, enclosed in 15% gelatin, inﬁltrated stepwise with 0.6, 1.2
and 2.3M sucrose, and then frozen in liquid nitrogen. Frozen ultrathin sections were
prepared at  110 C according to Tokuyasu. Brieﬂy, immuno-gold staining using
mouse anti-Myc antibody (1:10) was followed by several rinses in PBS and
incubation with 12-nm gold-labelled donkey anti-mouse IgG (715-205-150, Jackson
Immunoresearch Laboratories, Inc., Bar Harbor, ME, USA) as described by Roth
et al. Ultrathin frozen sections were observed with a Hitachi H-7650 electron
microscope at 80 kV. The images were recorded using an 11-megapixel CCD
XR611-M digital camera (Advanced Microscopy Techniques, Woburn, MA, USA).
HCMV infection. The AD169 strain of HCMV was used in this study. Virus was
maintained in HFF monolayers. To infect Caco-2 cells with AD169, monolayers
were plated in 24-well plates and media was replaced with fresh DMEM before
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infection. HCMV infection was enhanced by centrifugation at 940g for 45min.
After centrifugation, cells were incubated for 3 h at 37 C in an atmosphere of 5%
CO2, washed two times with PBS, and then supplied with fresh complete media.
Production of GST fusion proteins. Escherichia coli BL21 (DE3) expressing the
appropriate GST fusion protein was cultured in LB broth. The proteins were
induced with 0.5mM isopropyl-b-D-thiogalactoside at 28 C for 5 h, followed by
centrifugation, and resuspended in PBS (137mM NaCl, 2.7mM KCl, 10mM
Na2HPO4, 2mM KH2PO4) with EDTA-free protease inhibitors. Cells were soni-
cated and then centrifuged for 20min at 4 C. Extracts were incubated with 80 ml
GST-bind agarose resin for 2 h at 4 C. After washing with PBS, the beads with the
GST fusion proteins were eluted with 20mM GSH in PBS.
Crosslinking experiment. Crosslinking reactions were carried out as described
previously42. Brieﬂy, liposomes consisting of 20% NBD–PE/80% PC or 20%NBP-
Sphingosine/80%POPC and crosslinker N-a-maleimidoacet-oxysuccinimide ester
(AMAS) dissolved in DMSO were incubated at 30 C for 30min in reaction buffer
(100mM HEPES/NaOH (pH 7.3), 150mM NaCl) and further incubated for 15min
after the addition of 1M glycine in reaction buffer (ﬁnal concentration: 48mM).
GST fusion recombinant proteins (ﬁnal concentration: 93.75mgml 1) were added
to the reaction mixtures, which were then incubated at 30 C for 30min.
Crosslinking was terminated by the addition of 5 SDS loading buffer. Samples
were resolved by SDS–PAGE and analysed by an LAS image analyser for the
detection of NBD ﬂuorescence (excitation 460 nm/emission 515 nm) followed by
Coommassie Brilliant Blue staining.
Protein-lipid overlay assay. Lipids were solubilized in a solution of
MeOH:CHCl3:H2O (2:1:0.8), spotted onto Hybond-C extra Nitrocellulose (GE
Healthcare), and allowed to dry. The nitrocellulose was then blocked with 1% fat-
free skim milk in PBS-T for 1 h and incubated overnight at 4 C in the PBS-T
solution containing puriﬁed GST-recombinant protein (2 mgml 1). The strips
were washed 3 times with PBS-T and incubated with anti-GST antibody for 1 h.
The membrane was washed as before prior to incubation with horseradish
peroxidase-conjugated-anti-rabbit Ig antibody. Finally, the membrane was washed
three times with PBS-T and proteins associated with the phospholipids were
visualized using enhanced chemiluminescence.
Mitochondria puriﬁcation. Mitochondrial and cytosolic fractions were obtained
by using the Mitochondria Isolation Kit for Cultured Cells (#89874, Thermo Sci-
entiﬁc, Rockford, IL, USA). Brieﬂy, 7 106 cells were pelleted by centrifugation at
300g for 2min and mitochondria isolation reagent A was added to the pellet. Cells
were vortexed for 5 s and then incubated on ice for 2min. Mitochondria isolation
reagent B was added, followed by vortexing for 5 s. Tubes were incubated on ice for
5min and vortexed every 1min. Mitochondria isolation reagent C was added, and
the tubes were inverted several times. The supernatant obtained by centrifugation
at 700g for 10min at 4 C was transferred to a new tube and centrifuged at 3,000g
for 15min. Mitochondria isolation reagent C was added to the pellet and
centrifuged at 16,000g for 5min. The pellet containing the mitochondrial fraction
was resuspended in SDS loading buffer and analysed by immunoblot analysis. For
alkali extraction, mitochondrial pellets were resuspended in a buffer (20mM
Hepes, 0.05mM EDTA, 2mM MgCl2, Complete Mini Protease Inhibitor Cocktail,
pH 7.4). The same volume of 0.2M NaCl or 0.2M Na2CO3 was added, and
then incubation was continued for 30min on ice. Pellets were recovered by
centrifugation (100,000g, 30min, 4 C), and both pellet and supernatant fractions
were analysed by western blotting.
Statistical analysis. All experiments were repeated at least three times with
consistent results. Data are presented as mean and s.d. (as noted in ﬁgure legends).
Statistical differences between two means were evaluated with the two-tailed
unpaired Student’s t-test. Differences with P values below 0.05 were considered
signiﬁcant. All data were normally distributed and the variances were similar
between the groups being statistically compared. Sample size was based on previous
experience with experimental variability, and no statistical method was used to
predetermine sample sizes. No samples were excluded from the analysis. The
experiments were not randomized. The investigators were not blinded to allocation
during experiments or outcome assessment.
Data availability. The authors declare that the data supporting the ﬁndings of this
study are available within the article and its Supplementary Information ﬁles, or
from the corresponding authors upon request.
References
1. Levine, B. & Kroemer, G. Autophagy in the pathogenesis of disease. Cell 132,
27–42 (2008).
2. Xavier, R. J., Huett, A. & Rioux, J. D. Autophagy as an important process in gut
homeostasis and Crohn’s disease pathogenesis. Gut. 57, 717–720 (2008).
3. Berkes, J., Viswanathan, V. K., Savkovic, S. D. & Hecht, G. Intestinal epithelial
responses to enteric pathogens: effects on the tight junction barrier, ion
transport, and inﬂammation. Gut. 52, 439–451 (2003).
4. Levine, B., Mizushima, N. & Virgin, H. W. Autophagy in immunity and
inﬂammation. Nature 469, 323–335 (2011).
5. Mizushima, N., Yoshimori, T. & Ohsumi, Y. The role of Atg proteins in
autophagosome formation. Annu. Rev. Cell. Dev. Biol. 27, 107–132 (2011).
6. Mizushima, N., Levine, B., Cuervo, A. M. & Klionsky, D. J. Autophagy ﬁghts
disease through cellular self-digestion. Nature 451, 1069–1075 (2008).
7. Xavier, R. J. & Podolsky, D. K. Unravelling the pathogenesis of inﬂammatory
bowel disease. Nature 448, 427–434 (2007).
8. Hampe, J. et al. A genome-wide association scan of nonsynonymous SNPs
identiﬁes a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39,
207–211 (2007).
9. Rioux, J. D. et al. Genome-wide association study identiﬁes new susceptibility
loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat.
Genet. 39, 596–604 (2007).
10. Wellcome Trust Case Control, C. Genome-wide association study of 14,000
cases of seven common diseases and 3,000 shared controls. Nature 447,
661–678 (2007).
11. Cadwell, K. et al. A key role for autophagy and the autophagy gene Atg16l1 in
mouse and human intestinal Paneth cells. Nature 456, 259–263 (2008).
12. Kuma, A. et al. The role of autophagy during the early neonatal starvation
period. Nature 432, 1032–1036 (2004).
13. Komatsu, M. et al. Impairment of starvation-induced and constitutive
autophagy in Atg7-deﬁcient mice. J. Cell Biol. 169, 425–434 (2005).
14. Nishida, Y. et al. Discovery of Atg5/Atg7-independent alternative
macroautophagy. Nature 461, 654–658 (2009).
15. Collins, C. A. et al. Atg5-independent sequestration of ubiquitinated
mycobacteria. PLoS Pathog. 5, e1000430 (2009).
16. Steele, S. et al. Francisella tularensis harvests nutrients derived via ATG5-
independent autophagy to support intracellular growth. PLoS Pathog. 9,
e1003562 (2013).
17. Meroni, G. & Diez-Roux, G. TRIM/RBCC, a novel class of ‘single protein RING
ﬁnger’ E3 ubiquitin ligases. Bioessays 27, 1147–1157 (2005).
18. Tomar, D., Singh, R., Singh, A. K., Pandya, C. D. & Singh, R. TRIM13 regulates
ER stress induced autophagy and clonogenic ability of the cells. Biochim.
Biophys. Acta 1823, 316–326 (2012).
19. Mandell, M. A. et al. TRIM proteins regulate autophagy and can target
autophagic substrates by direct recognition. Dev. Cell 30, 394–409 (2014).
20. Khan, M. M. et al. Role of autophagy, SQSTM1, SH3GLB1, and TRIM63 in the
turnover of nicotinic acetylcholine receptors. Autophagy 10, 123–136 (2014).
21. Sugiura, T. & Miyamoto, K. Characterization of TRIM31, upregulated in gastric
adenocarcinoma, as a novel RBCC protein. J. Cell. Biochem. 105, 1081–1091
(2008).
22. Fujiki, Y., Hubbard, A. L., Fowler, S. & Lazarow, P. B. Isolation of intracellular
membranes by means of sodium carbonate treatment: application to
endoplasmic reticulum. J. Cell Biol. 93, 97–102 (1982).
23. Burri, L. et al. Integral membrane proteins in the mitochondrial outer
membrane of Saccharomyces cerevisiae. FEBS J. 273, 1507–1515 (2006).
24. Chin, A. C. & Parkos, C. A. Pathobiology of neutrophil transepithelial
migration: implications in mediating epithelial injury. Annu. Rev. Pathol. 2,
111–143 (2007).
25. Fournier, B. M. & Parkos, C. A. The role of neutrophils during intestinal
inﬂammation. Mucosal Immunol. 5, 354–366 (2012).
26. Hailey, D. W. et al. Mitochondria supply membranes for autophagosome
biogenesis during starvation. Cell 141, 656–667 (2010).
27. Ouellette, A. J. Paneth cell alpha-defensin synthesis and function. Curr. Top.
Microbiol. Immunol. 306, 1–25 (2006).
28. Kabeya, Y. et al. LC3, a mammalian homologue of yeast Apg8p, is localized in
autophagosome membranes after processing. EMBO J. 19, 5720–5728 (2000).
29. Kabeya, Y. et al. LC3, GABARAP and GATE16 localize to autophagosomal
membrane depending on form-II formation. J. Cell Sci. 117, 2805–2812 (2004).
30. Bjorkoy, G. et al. p62/SQSTM1 forms protein aggregates degraded by
autophagy and has a protective effect on huntingtin-induced cell death. J. Cell
Biol. 171, 603–614 (2005).
31. Komatsu, M. et al. Homeostatic levels of p62 control cytoplasmic inclusion
body formation in autophagy-deﬁcient mice. Cell 131, 1149–1163 (2007).
32. Gal, J., Strom, A. L., Kilty, R., Zhang, F. & Zhu, H. p62 accumulates and
enhances aggregate formation in model systems of familial amyotrophic lateral
sclerosis. J. Biol. Chem. 282, 11068–11077 (2007).
33. Ichimura, Y. et al. A ubiquitin-like system mediates protein lipidation. Nature
408, 488–492 (2000).
34. Nakatogawa, H., Ichimura, Y. & Ohsumi, Y. Atg8, a ubiquitin-like protein
required for autophagosome formation, mediates membrane tethering and
hemifusion. Cell 130, 165–178 (2007).
35. Shao, Y., Gao, Z., Feldman, T. & Jiang, X. Stimulation of ATG12-ATG5
conjugation by ribonucleic acid. Autophagy 3, 10–16 (2007).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11726
14 NATURE COMMUNICATIONS | 7:11726 | DOI: 10.1038/ncomms11726 | www.nature.com/naturecommunications
36. Kimura, S., Noda, T. & Yoshimori, T. Dissection of the autophagosome
maturation process by a novel reporter protein, tandem ﬂuorescent-tagged LC3.
Autophagy 3, 452–460 (2007).
37. Ravikumar, B., Moreau, K., Jahreiss, L., Puri, C. & Rubinsztein, D. C. Plasma
membrane contributes to the formation of pre-autophagosomal structures. Nat.
Cell Biol. 12, 747–757 (2010).
38. Delgado, M. A., Elmaoued, R. A., Davis, A. S., Kyei, G. & Deretic, V. Toll-like
receptors control autophagy. EMBO J. 27, 1110–1121 (2008).
39. Xu, Y. et al. Toll-like receptor 4 is a sensor for autophagy associated with innate
immunity. Immunity 27, 135–144 (2007).
40. Fujita, N. et al. An Atg4B mutant hampers the lipidation of LC3 paralogues and
causes defects in autophagosome closure. Mol. Biol. Cell 19, 4651–4659 (2008).
41. Weidberg, H. et al. LC3 and GATE-16N termini mediate membrane fusion
processes required for autophagosome biogenesis. Dev. Cell 20, 444–454 (2011).
42. Hanada, T. et al. The Atg12-Atg5 conjugate has a novel E3-like activity for
protein lipidation in autophagy. J. Biol. Chem. 282, 37298–37302 (2007).
43. Dowler, S., Kular, G. & Alessi, D. R. Protein lipid overlay assay. Sci. STKE 2002,
pl6 (2002).
44. Papadopoulos, T., Schemm, R., Grubmuller, H. & Brose, N. Lipid binding
defects and perturbed synaptogenic activity of a Collybistin R290H mutant that
causes epilepsy and intellectual disability. J. Biol. Chem. 290, 8256–8270 (2015).
45. Henry, S. C., Schmidt, E. A., Fessler, M. B. & Taylor, G. A. Palmitoylation of the
immunity related GTPase, Irgm1: impact on membrane localization and ability
to promote mitochondrial ﬁssion. PLoS ONE 9, e95021 (2014).
46. Singh, S. B., Davis, A. S., Taylor, G. A. & Deretic, V. Human IRGM induces
autophagy to eliminate intracellular mycobacteria. Science 313, 1438–1441
(2006).
47. Singh, S. B. et al. Human IRGM regulates autophagy and cell-autonomous
immunity functions through mitochondria. Nat. Cell Biol. 12, 1154–1165
(2010).
48. Aicart-Ramos, C., Valero, R. A. & Rodriguez-Crespo, I. Protein palmitoylation
and subcellular trafﬁcking. Biochim. Biophys. Acta 1808, 2981–2994 (2011).
49. Salaun, C., Greaves, J. & Chamberlain, L. H. The intracellular dynamic of
protein palmitoylation. J. Cell. Biol. 191, 1229–1238 (2010).
50. Ren, J. et al. CSS-Palm 2.0: an updated software for palmitoylation sites
prediction. Protein Eng. Des. Sel. 21, 639–644 (2008).
51. Webb, Y., Hermida-Matsumoto, L. & Resh, M. D. Inhibition of protein
palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and
polyunsaturated fatty acids. J. Biol. Chem. 275, 261–270 (2000).
52. Frohlich, M., Dejanovic, B., Kashkar, H., Schwarz, G. & Nussberger, S.
S-palmitoylation represents a novel mechanism regulating the mitochondrial
targeting of BAX and initiation of apoptosis. Cell Death Dis. 5, e1057 (2014).
53. McLaughlin, R. E. & Denny, J. B. Palmitoylation of GAP-43 by the ER-Golgi
intermediate compartment and Golgi apparatus. Biochim. Biophys. Acta 1451,
82–92 (1999).
54. Li, L., Haynes, M. P. & Bender, J. R. Plasma membrane localization and
function of the estrogen receptor alpha variant (ER46) in human endothelial
cells. Proc. Natl Acad. Sci. USA 100, 4807–4812 (2003).
55. Zychlinsky, A., Prevost, M. C. & Sansonetti, P. J. Shigella ﬂexneri induces
apoptosis in infected macrophages. Nature 358, 167–169 (1992).
56. Mathan, M. M. & Mathan, V. I. Ultrastructural pathology of the rectal mucosa
in Shigella dysentery. Am. J. Pathol. 123, 25–38 (1986).
57. Mounier, J., Vasselon, T., Hellio, R., Lesourd, M. & Sansonetti, P. J. Shigella
ﬂexneri enters human colonic Caco-2 epithelial cells through the basolateral
pole. Infect. Immun. 60, 237–248 (1992).
58. Mostowy, S. et al. p62 and NDP52 proteins target intracytosolic Shigella and
Listeria to different autophagy pathways. J. Biol. Chem. 286, 26987–26995
(2011).
59. Benjamin, J. L., Sumpter, Jr R., Levine, B. & Hooper, L. V. Intestinal epithelial
autophagy is essential for host defense against invasive bacteria. Cell Host
Microbe 13, 723–734 (2013).
60. Kim, J. M. et al. Apoptosis of human intestinal epithelial cells after bacterial
invasion. J. Clin. Invest. 102, 1815–1823 (1998).
61. Hilbi, H. et al. Shigella-induced apoptosis is dependent on caspase-1 which
binds to IpaB. J. Biol. Chem. 273, 32895–32900 (1998).
62. Henson, D. Cytomegalovirus inclusion bodies in the gastrointestinal tract. Arch.
Pathol. 93, 477–482 (1972).
63. Kishore, J. et al. Infection with cytomegalovirus in patients with inﬂammatory
bowel disease: prevalence, clinical signiﬁcance and outcome. J. Med. Microbiol.
53, 1155–1160 (2004).
64. Onyeagocha, C. et al. Latent cytomegalovirus infection exacerbates
experimental colitis. Am. J. Pathol. 175, 2034–2042 (2009).
65. Dimitroulia, E., Spanakis, N., Konstantinidou, A. E., Legakis, N. J. & Tsakris, A.
Frequent detection of cytomegalovirus in the intestine of patients with
inﬂammatory bowel disease. Inﬂamm. Bowel. Dis. 12, 879–884 (2006).
66. Ciccocioppo, R. et al. Human cytomegalovirus and Epstein-Barr virus infection
in inﬂammatory bowel disease: need for mucosal viral load measurement.
World J. Gastroenterol. 21, 1915–1926 (2015).
67. Mrosek, M. et al. Structural analysis of B-Box 2 from MuRF1: identiﬁcation
of a novel self-association pattern in a RING-like fold. Biochemistry 47,
10722–10730 (2008).
68. Gottlieb, C. D., Zhang, S. & Linder, M. E. The cysteine-rich domain of the
DHHC3 palmitoyltransferase is palmitoylated and contains tightly bound zinc.
J. Biol. Chem. 290, 29259–29269 (2015).
69. Fairbank, M., Huang, K., El-Husseini, A. & Nabi, I. R. RING ﬁnger
palmitoylation of the endoplasmic reticulum Gp78 E3 ubiquitin ligase. FEBS
Lett. 586, 2488–2493 (2012).
70. Janeway, Jr C. A. & Medzhitov, R. Innate immune recognition. Annu. Rev.
Immunol. 20, 197–216 (2002).
Acknowledgements
We thank Dr Noboru Mizushima (The University of Tokyo, Japan), Dr Komatsu
Masaaki (Tokyo Metropolitan Institute of Medical Science, Japan), and Dr Dong Wook
Kim (Department of Pharmacy, Hanyang Univeristy, South Korea) for Tet-regulated
Atg5 / , Atg7 / MEF cells, and Shigella M90T strains, respectively. This study was
supported by grants from the Korean Health Technology R&D Project, Ministry of
Health & Welfare, Republic of Korea (HI14C2542), and from Basic Science Research
Program through the National Research Foundation of Korea (NRF) funded by the
Ministry of Science, ICT and future planning (NRF-2015R1A2A1A15055053). This work
was also supported (in part) by the Yonsei University Future-leading Research Initiative
of 2015 (2015-22-0082), and by the Strategic Initiative for Microbiomes in Agriculture
and Food funded by Ministry of Agriculture, Food and Rural Affairs (916006-2). S.L. was
supported by Basic Science Research Program through the National Research Foundation
of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A01060181). I.J.
was supported (in part) by the Yonsei University Research Fund (Post Doc. Researcher
Supporting Program) of 2015 (2015-12-0213). J.W.C. was supported by the Basic Science
Research Program through the National Research Foundation of Korea (NRF) funded by
the Ministry of Education, Science and Technology (NRF-2013R1A2A1A01008067), and
by the Bio & Medical Technology Development Program of the NRF funded by the
Ministry of Science, ICT & Future Planning (NRF-2015M3A9B6073840). E.A.R., T.A.L.,
A.P., and S. K were supported by Brain Korea (BK21) PLUS Program. H.J.C. was
supported by NRF (National Research Foundation of Korea) grant funded by the Korean
Government (NRF-2013- Global Ph.D. Fellowship Program).
Author contributions
E.A.R., T.A.L., S.W.K., A.P., H.J.C., I.J. and S.K. conducted experiments; E.A.R., S.L
and B.P. designed experiments, analysed data, and wrote the manuscript; J.W.C. advised
on EM; J.H.C. and J.E.L. contributed all clinical studies and advised on experimental
designs.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Ra, E. A. et al. TRIM31 promotes Atg5/Atg7-independent
autophagy in intestinal cells. Nat. Commun. 7:11726 doi: 10.1038/ncomms11726 (2016).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11726 ARTICLE
NATURE COMMUNICATIONS | 7:11726 | DOI: 10.1038/ncomms11726 | www.nature.com/naturecommunications 15
